Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non-Current Liabilities (2018 - 2024)

Pharma-Bio Serv (PBSV) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $660903.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Liabilities changed N/A year-over-year to $660903.0, compared with a TTM value of $660903.0 through Oct 2024, changed N/A, and an annual FY2024 reading of $660903.0, changed N/A over the prior year.
  • Other Non-Current Liabilities was $660903.0 for Q4 2024 at Pharma-Bio Serv, down from $1.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.6 million in Q4 2022 and bottomed at $17950.0 in Q1 2020.
  • Average Other Non-Current Liabilities over 5 years is $385000.7, with a median of $17950.0 recorded in 2020.
  • The sharpest move saw Other Non-Current Liabilities crashed 75.54% in 2021, then soared 9031.19% in 2022.
  • Year by year, Other Non-Current Liabilities stood at $73389.0 in 2020, then plummeted by 75.54% to $17950.0 in 2021, then skyrocketed by 9031.19% to $1.6 million in 2022, then fell by 12.9% to $1.4 million in 2023, then plummeted by 53.7% to $660903.0 in 2024.
  • Business Quant data shows Other Non-Current Liabilities for PBSV at $660903.0 in Q4 2024, $1.4 million in Q3 2023, and $1.4 million in Q2 2023.